It is estimated that the global IPF treatment market is expected to register a CAGR of 12.3% during the forecast period of 2022 to 2027
The global immunoassay market size accounted for USD 18,626.7 million in 2022 and is projected to register a CAGR of 5.9% over the forecast period
Providing detailed care to patients suffering from damaged vessels during an operation is of utmost importance as this can trigger substantial blood loss
beauty devices market that estimates an enormous boost for this market with 7.8% CAGR (Compound Annual Growth Rate) between 2022 and 2027.
The global endoscopy device market will grow at a CAGR of 6.30% during the forecast period 2022 to 2027
Market Research Future (MRFR) assessed the global LASIK eye surgerys market 2021 in the analysis period till 2027
The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period
According to a recent study report published by the Market Research Future analysts, the global bronchoscopes market is growing at a moderate pace
The global halitosis treatment market has been segmented on the basis of indication, type, drug treatment, and diagnostic test.
A CAGR of 7.8 per cent is expected for the forecast period between 2022 and 2027, bringing the total global cosmetic surgery market to USD 21.97 billion
The global automated hospital beds market is reported to grow at a steady and decent pace as per the recently released report by Market Research Future (MRFR)
The global immunoprecipitation market is predicted to touch USD 562 million at a 5.2% CAGR over the forecast period
Bioimplants are essential in medical procedures which are conducted to recover the functionality of damaged bio structure
Market Research Future (MRFR) anticipates the biosurgery market to attain a healthy CAGR around 7.0% from 2022 to 2027
As per Market Research Future (MRFR)’s latest report, the global blood transfusion diagnostics market is set to expand at a CAGR of 8.2% during the forecast period